Condition
    Effectiveness 4/5

    Vitamin B2 for Riboflavin Deficiency

    This is the rare supplement pairing where the answer is simply yes: riboflavin deficiency is corrected by riboflavin. Clinical signs — cracked mouth corners, sore tongue, eye irritation — typically resolve within two to four weeks of supplementation or dietary correction. The supplement treats the deficiency; the diet prevents the recurrence.

    Overview

    Riboflavin deficiency is one of the few nutritional problems where supplementation is close to definitive: give the vitamin, and the deficiency resolves. The signs are unglamorous but recognisable — cracking at the corners of the mouth, a sore magenta tongue, a scaly rash around the nose and mouth, gritty light-sensitive eyes and sometimes a normocytic anaemia. What makes this pair worth taking seriously is how often marginal deficiency goes unnoticed. It is common in people avoiding dairy, in pregnancy, in older adults with restricted diets, and in those with the MTHFR 677TT genotype, whose enzyme depends on riboflavin-derived FAD. Correction is cheap, fast and essentially without downside.

    Verdict

    Likely effective

    Randomised trials show riboflavin supplementation corrects biochemical deficiency, resolves the mucocutaneous signs and improves haematologic status in marginally deficient women. Genotype-targeted trials also show blood pressure benefit in MTHFR 677TT.

    How It Works

    Riboflavin is the precursor of two coenzymes, FMN and FAD, which carry electrons in dozens of reactions. Without them the mitochondrial respiratory chain, fatty acid beta-oxidation and glutathione reductase all lose capacity. Tissues with fast turnover and high energy demand feel it first, which is why the mouth, tongue, skin and cornea show the earliest signs. Two downstream links explain the wider effects. FAD is the cofactor for MTHFR, so riboflavin status determines how well that enzyme works and therefore homocysteine handling — the basis for the blood pressure trials in the 677TT genotype. FAD is also needed to mobilise iron from ferritin, which is why correcting riboflavin improves haemoglobin even when iron intake has not changed.

    Pathways involved

    FMN and FAD coenzyme synthesis
    Mitochondrial electron transport
    Glutathione reductase antioxidant recycling
    MTHFR activity and homocysteine handling
    Iron mobilisation from ferritin

    Dosing & Protocol

    Correcting deficiency needs surprisingly little. Adult requirements are around 1.1 to 1.3 mg daily, and 5 to 25 mg daily comfortably repletes stores within weeks. A standard B-complex covers it, and dietary sources — dairy, eggs, liver, almonds, mushrooms and fortified cereals — should be part of the plan since deficiency rarely occurs alone. One number causes persistent confusion. The 400 mg daily dose used in migraine prophylaxis trials is a pharmacological intervention for a different indication, not a deficiency correction dose. Riboflavin is absorbed by a saturable transporter, so single doses above roughly 25 mg are largely excreted; splitting large doses is the only way to raise absorbed amounts.
    ScenarioDoseFormTiming
    Deficiency correction5-25 mg dailyRiboflavin or riboflavin-5-phosphateWith food, morning
    Maintenance after correction1.3-3 mg dailyB-complexWith food
    MTHFR 677TT, blood pressure1.6 mg daily (trial dose)RiboflavinDaily, alongside usual medication
    Migraine prophylaxis (separate indication)400 mg dailyRiboflavinWith food, often split
    1. 1

      Match the signs to the deficiency· Before starting

      Angular cheilitis, glossitis, seborrhoeic-type facial rash and photophobia together are suggestive. Erythrocyte glutathione reductase activation coefficient is the formal test where available.

    2. 2

      Start 10-25 mg daily· Weeks 1-4

      Take with food. Expect bright yellow urine within hours; this is unabsorbed riboflavin, not a problem.

    3. 3

      Fix the diet alongside· Ongoing

      Add dairy or fortified alternatives, eggs, almonds and mushrooms. Isolated riboflavin deficiency is unusual, so other B vitamins deserve attention.

    4. 4

      Reassess at 4 weeks· Week 4

      Mouth, tongue and eye signs should be resolving. Persistence points to another cause.

    5. 5

      Drop to maintenance· Month 2 onward

      Once signs clear, a standard B-complex or improved diet is sufficient. High-dose supplementation is not needed indefinitely.

    Evidence

    The most directly relevant trial is RIBOFEM, a randomised study in young women in the United Kingdom with marginal riboflavin deficiency, where correction improved haematologic status — evidence that marginal deficiency is functionally meaningful rather than merely biochemical. A recent review of the causes and clinical sequelae of riboflavin deficiency summarises the mucocutaneous, ocular and haematologic picture and the populations at risk. Two randomised trials in people homozygous for the MTHFR 677C to T polymorphism found that riboflavin lowered blood pressure in cardiovascular disease patients and in treated hypertensive individuals, a genotype-specific effect that reinforces how riboflavin status governs MTHFR function. Separately, randomised evidence and a meta-analysis support high-dose riboflavin for migraine prophylaxis — a distinct indication included here only to keep the dose distinction clear.
    Best available evidence
    Randomised controlled trials plus a recent systematic review
    Typical effect
    Biochemical correction within days; mucocutaneous signs resolve over 2-4 weeks
    Studied dose
    1.6-25 mg daily for deficiency; 400 mg daily in migraine trials
    Time to effect
    2-4 weeks for mouth, tongue and eye signs
    Certainty of evidence
    High for correcting deficiency; moderate for genotype-specific blood pressure effects

    A review of the causes and clinical sequelae of riboflavin deficiency, the RIBOFEM randomised trial in marginally deficient women, two genotype-targeted blood pressure trials, and randomised and meta-analytic evidence for high-dose riboflavin in migraine.

    Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial

    Score: 7/10
    1998
    rct
    n=55

    Schoenen J, Jacquy J, Lenaerts M

    Riboflavin was superior to placebo, with 59% versus 15% of patients achieving at least a 50% reduction in attacks.

    View source

    Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM)

    Score: 7/10
    2011
    rct
    n=123

    Powers HJ

    Moderately poor riboflavin status can affect iron status: the lower the riboflavin status, the greater the hematologic benefits of improving status.

    View source

    Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial

    Score: 7/10
    2013
    rct
    n=91

    Wilson CP

    Riboflavin supplementation targeted at hypertensive individuals with the MTHFR 677TT genotype can decrease BP more effectively than treatment with current antihypertensive drugs only.

    View source

    Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis

    Score: 7/10
    2022
    meta_analysis
    n=673

    Chen YS

    Vitamin B2 400 mg/day for three months supplementation had significant effect on days, duration, frequency, and pain score of migraine attacks.

    View source

    Causes and Clinical Sequelae of Riboflavin Deficiency

    Score: 5/10
    2023
    systematic_review

    McNulty H, Pentieva K, Ward M

    There are adverse health consequences of low and deficient riboflavin status throughout the life cycle, including anemia and hypertension.

    View source

    Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-->T polymorphism in MTHFR

    Score: 7/10
    2010
    rct
    n=181

    Horigan G

    Riboflavin is effective in reducing blood pressure specifically in patients with the MTHFR 677 TT genotype.

    View source

    Safety

    Riboflavin is among the safest supplements available. It is water soluble, absorption is saturable, and excess is excreted in urine, which turns a harmless bright yellow. No tolerable upper intake level has been set because no consistent adverse effect has been identified, and even 400 mg daily in migraine trials produced only occasional diarrhoea and increased urination. The real risk is misattribution. Angular cheilitis and glossitis also arise from iron, B12 or folate deficiency, poorly fitting dentures, candida and diabetes. If the mouth signs persist after four weeks of adequate riboflavin, the diagnosis needs revisiting rather than the dose increasing.

    Persistent signs need a wider look

    Cracked mouth corners, a sore tongue or a rash that does not settle after four weeks of riboflavin warrant checks for iron, B12 and folate deficiency, coeliac disease, candida and diabetes.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Tricyclic antidepressants and phenothiazines
    moderate
    		These drugs inhibit conversion of riboflavin to FAD and can precipitate deficiencyConsider routine riboflavin intake if on long-term therapy
    Tetracycline antibiotics
    low
    		Mutual interference with absorptionSeparate doses by 2 hours
    Alcohol (chronic use)
    moderate
    		Impairs riboflavin absorption and conversion to coenzyme formsAddress intake; deficiency often recurs otherwise
    Probenecid
    low
    		Reduces renal excretion and gastrointestinal absorption of riboflavinNo action usually needed; monitor for deficiency signs
    Anticholinergic drugs
    low
    		Slowed gastric emptying can alter absorptionTake riboflavin with food consistently
    Photosensitising drugs
    low
    		Riboflavin is degraded by light and shares photochemical activityStore away from light; no dose change needed

    References

    1. Powers HJ et al. Correcting a marginal riboflavin deficiency improves hematologic status in young women in the UK (RIBOFEM). Am J Clin Nutr. 2011
    2. Causes and Clinical Sequelae of Riboflavin Deficiency. Annu Rev Nutr. 2023
    3. Wilson CP et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to riboflavin. Hypertension. 2013

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.